CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain
- 5 February 2020
- journal article
- research article
- Published by Taylor & Francis in Epigenetics
- Vol. 15 (8) , 781-799
Abstract
The Presenilin1 (PSEN1) gene encodes the catalytic peptide of the γ-secretase complex, a key enzyme that cleaves the amyloid-β protein precursor (AβPP), to generate the amyloid-β (Aβ) peptides, involved in Alzheimer’s Disease (AD). Other substrates of the γ-secretase, such as E-cadherin and Notch1, are involved in neurodevelopment and haematopoiesis. Gene-specific DNA methylation influences PSEN1 expression in AD animal models. Here we evaluated canonical and non-canonical cytosine methylation patterns of the PSEN1 5ʹ-flanking during brain development and AD progression, in DNA extracted from the frontal cortex of AD transgenic mice (TgCRND8) and post-mortem human brain. Mapping CpG and non-CpG methylation revealed different methylation profiles in mice and humans. PSEN1 expression only correlated with DNA methylation in adult female mice. However, in post-mortem human brain, lower methylation, both at CpG and non-CpG sites, correlated closely with higher PSEN1 expression during brain development and in disease progression. PSEN1 methylation in blood DNA was significantly lower in AD patients than in controls. The present study is the first to demonstrate a temporal correlation between dynamic changes in PSEN1 CpG and non-CpG methylation patterns and mRNA expression during neurodevelopment and AD neurodegeneration. These observations were made possible by the use of an improved bisulphite methylation assay employing primers that are not biased towards non-CpG methylation. Our findings deepen the understanding of γ-secretase regulation and support the hypothesis that epigenetic changes can promote the pathophysiology of AD. Moreover, they suggest that PSEN1 DNA methylation in peripheral blood may provide a biomarker for AD.Keywords
Funding Information
- FP7 International Cooperation (278486)
- Ministero della Salute (GR-2009-1606229)
- Spanish Ministry of Health (PI1100968)
This publication has 52 references indexed in Scilit:
- Global Epigenomic Reconfiguration During Mammalian Brain DevelopmentScience, 2013
- Genomic Distribution and Inter-Sample Variation of Non-CpG Methylation across Human Cell TypesPLOS Genetics, 2011
- Epigenetic mechanisms in Alzheimer's diseaseNeurobiology of Aging, 2011
- Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5’-flanking regionCell Cycle, 2010
- Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseasesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2009
- Presenilin: RIP and beyondSeminars in Cell & Developmental Biology, 2009
- Age-Specific Epigenetic Drift in Late-Onset Alzheimer's DiseasePLOS ONE, 2008
- The γ-secretase complex: machinery for intramembrane proteolysisCurrent Opinion in Neurobiology, 2004
- Reconstitution of γ-secretase activityNature Cell Biology, 2003
- NOTCH ANDPRESENILIN: Regulated Intramembrane Proteolysis Links Development and DegenerationAnnual Review of Neuroscience, 2003